B3GAT1 and myeloid sarcoma: We and others previously reported that the immune system of MS patients displays different characteristic of senescence, such as higher percentages of terminally differentiated T cells expressing CD57 and PD-1 [21,37,38,39,40,41,42,43,44,45].